Learn more about our Advocacy work.
In a new op-ed in RealClear Health, AdvaMed® President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…
Today, diabetes was front and center during a Senate HELP Committee hearing, prompting AdvaMed® President and CEO Scott Whitaker to release the following statement on the ways life-saving medical technology…
Today, AdvaMedDx® submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx® is a division of AdvaMed® representing companies that develop in…
Today, AdvaMed® President and CEO Scott Whitaker released the following statement upon House passage of The Prematurity Research Expansion and Education for Mothers who deliver Infants Early (PREEMIE) Reauthorization Act:
In testimony today before a key congressional subcommittee hearing, AdvaMed, The Medtech Association®, called for a balance in the proposed regulations of the method used to sterilize 20 billion, or…
Today, AdvaMed, The Medtech Association®, called on congressional leaders to work together to prevent a federal government shutdown.
Today, following a legislative hearing on improving seniors’ access to innovative medical devices and technologies, AdvaMed® President and CEO Scott Whitaker commended the House Energy and Commerce Committee’s Subcommittee on…
Today, AdvaMed, The Medtech Association®, submitted a letter to the House Committee on Oversight and Accountability regarding the Committee’s consideration of an issue that threatens to undermine the foundations of…
In the latest episode of the Medtech POV Podcast, AdvaMed® President and CEO Scott Whitaker sits down with Dr. Peter Schneider and Dr. Justin Klein to talk about a recent…
Scott Whitaker, President and CEO, of AdvaMed® recently had the opportunity to speak with Ambassador Kurt Volker, a distinguished diplomat who served as U.S. Ambassador to NATO and U.S. Special…